United StatesCongress
hr 7473Bill

Generic Substitution Noninterference Act

To prohibit pharmaceutical manufacturers from interfering with therapeutically equivalent or interchangeable substitution decisions by health care providers to limit competition from a generic drug or biosimilar biological product, and for other purposes.

Introduced on April 7, 2022

House
Senate
President